Evergreen Capital reports 9.99% stake in C3is
Evergreen Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 9.99% of C3is Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Evergreen Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 9.99% of C3is Inc. common stock. The firm reports beneficial ownership of 443,213 securities, consisting of 425,000 common shares and 18,213 pre-funded warrants to purchase common shares. The 9.99% figure is based on 4,418,378 C3is common shares outstanding after an offering, as described in a prospectus filed under Rule 424(b)(4). Evergreen notes additional pre-funded and Series D and E warrants to purchase common shares that are subject to a 9.99% beneficial ownership limitation, so these are not included in the reported amount. The filing certifies that the securities are not held for the purpose of changing or influencing control of C3is Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in C3is Inc. (CISS) does Evergreen Capital Management LLC report?
How many C3is Inc. securities does Evergreen Capital Management LLC beneficially own?
Does Evergreen Capital Management LLC hold additional C3is warrants not counted in the 9.99% stake?
Is Evergreen Capital Management LLC seeking to influence control of C3is Inc.?
Who signs the Schedule 13G/A filing for Evergreen Capital Management LLC regarding C3is (CISS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.